---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-178820"
form_type: "8-K"
ticker: "VRDN"
cik: "0001590750"
company_name: "Viridian Therapeutics, Inc.\\DE"
filed_at: "2024-07-15T23:59:59+00:00"
generated_at: "2026-05-31T20:42:22.009503+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Viridian Therapeutics posts updated investor presentation on website

## Summary
- Updated corporate presentation available on company website, dated July 2024.
- No financial results, guidance changes, or material events disclosed in the filing.
- Presentation likely covers pipeline updates and corporate strategy.

## SEC filing metadata
- accession: 0001193125-24-178820
- form_type: 8-K
- ticker: VRDN
- cik: 0001590750
- company_name: Viridian Therapeutics, Inc.\DE
- filed_at: 2024-07-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590750/000119312524178820/0001193125-24-178820-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590750/000119312524178820/d840470d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-178820
- JSON: https://secwatch.observer/filing/0001193125-24-178820.json
- Plain text: https://secwatch.observer/filing/0001193125-24-178820.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.